找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Estrogen Receptor and Breast Cancer; Celebrating the 60th Xiaoting Zhang Book 2019 Springer Nature Switzerland AG 2019 estrogen receptor.br

[复制链接]
查看: 45985|回复: 50
发表于 2025-3-21 16:44:12 | 显示全部楼层 |阅读模式
书目名称Estrogen Receptor and Breast Cancer
副标题Celebrating the 60th
编辑Xiaoting Zhang
视频video
概述Written by World Renowned Leaders of the Estrogen Receptor and Breast Cancer Field to Celebrate the 60th Anniversary of the Discovery of Estrogen Receptor.Provides Comprehensive and Most Up-to-Date In
丛书名称Cancer Drug Discovery and Development
图书封面Titlebook: Estrogen Receptor and Breast Cancer; Celebrating the 60th Xiaoting Zhang Book 2019 Springer Nature Switzerland AG 2019 estrogen receptor.br
描述.The discovery of ER by Dr. Elwood Jensen exactly 60 years ago has not only led to the birth of a whole new vital nuclear receptor research field but also made a rapid, direct and lasting impact on the treatment and prevention of breast cancer. Since that landmark discovery, tremendous progress has been made in our understanding of the molecular functions of ER and development of targeted therapies against ER pathways for breast cancer treatment. However, there is currently no book available addressing these discoveries and recent advancement in a historical and systematic fashion. This book is intended to provide comprehensive, most up-to-date information on the history and recent advancement of ER and breast cancer by world renowned leaders in the field. These chapters include the history of the discovery of ER; physiological and pathological roles of ER; recent discovery of ER cistrome, transcriptome and its regulation of noncoding RNAs such as microRNAs and enhancer RNAs in breast cancer; development and clinical practices of the first targeted therapy Tamoxifen and other antiestrogens for breast cancer treatment; structural basis of ER and antiestrogen actions; molecular insig
出版日期Book 2019
关键词estrogen receptor; breast cancer; targeted therapies against ER pathways; Tamoxifen; molecular functions
版次1
doihttps://doi.org/10.1007/978-3-319-99350-8
isbn_softcover978-3-030-07593-4
isbn_ebook978-3-319-99350-8Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightSpringer Nature Switzerland AG 2019
The information of publication is updating

书目名称Estrogen Receptor and Breast Cancer影响因子(影响力)




书目名称Estrogen Receptor and Breast Cancer影响因子(影响力)学科排名




书目名称Estrogen Receptor and Breast Cancer网络公开度




书目名称Estrogen Receptor and Breast Cancer网络公开度学科排名




书目名称Estrogen Receptor and Breast Cancer被引频次




书目名称Estrogen Receptor and Breast Cancer被引频次学科排名




书目名称Estrogen Receptor and Breast Cancer年度引用




书目名称Estrogen Receptor and Breast Cancer年度引用学科排名




书目名称Estrogen Receptor and Breast Cancer读者反馈




书目名称Estrogen Receptor and Breast Cancer读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:39:41 | 显示全部楼层
https://doi.org/10.1007/978-3-031-29624-6r recruitment and selectivity, translating to varying degrees of receptor modulation and downstream functional effects. Dissecting these conformational state fluctuations within the context of variable cofactor profiles in different tissues, PTM induction, and emergence of hormonal treatment-related
发表于 2025-3-22 04:26:23 | 显示全部楼层
Cultural and Creative Mural Spacesne resistance include alterations of ER coregulators and pioneer factors, and genetic aberrations of ER itself. Recent advances in our understanding of the mechanisms of endocrine resistance, mostly provided by large-scale sequencing studies, further establish the roles of epigenetic alterations, th
发表于 2025-3-22 06:13:59 | 显示全部楼层
发表于 2025-3-22 09:56:30 | 显示全部楼层
Book 2019e, transcriptome and its regulation of noncoding RNAs such as microRNAs and enhancer RNAs in breast cancer; development and clinical practices of the first targeted therapy Tamoxifen and other antiestrogens for breast cancer treatment; structural basis of ER and antiestrogen actions; molecular insig
发表于 2025-3-22 13:51:45 | 显示全部楼层
The Estrogen-Regulated Transcriptome: Rapid, Robust, Extensive, and Transient,athways, impacting transcriptional programs and clinical outcomes in breast cancer. This chapter reviews the key features of ERα-regulated transcription and the current technological advances that have allowed for the careful dissection of these mechanisms.
发表于 2025-3-22 19:36:16 | 显示全部楼层
Structural Insights into Estrogen Receptors and Antiestrogen Therapies,r recruitment and selectivity, translating to varying degrees of receptor modulation and downstream functional effects. Dissecting these conformational state fluctuations within the context of variable cofactor profiles in different tissues, PTM induction, and emergence of hormonal treatment-related
发表于 2025-3-22 23:00:59 | 显示全部楼层
发表于 2025-3-23 05:10:50 | 显示全部楼层
Endocrine Disrupting Chemicals and Breast Cancer: The Saga of Bisphenol A,ogen whose adverse health effects have attracted considerable attention by scientists, industry, regulatory agencies, and the public at large. The disparate positions on health hazards by BPA, which have been undertaken by the chemical and food industries, environmental advocacy groups, health organ
发表于 2025-3-23 06:19:08 | 显示全部楼层
2196-9906 in breast cancer; development and clinical practices of the first targeted therapy Tamoxifen and other antiestrogens for breast cancer treatment; structural basis of ER and antiestrogen actions; molecular insig978-3-030-07593-4978-3-319-99350-8Series ISSN 2196-9906 Series E-ISSN 2196-9914
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-12 13:41
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表